Difference between revisions of "SERONEGATIVE ARTHRITIS-PSORIATIC ARTHRITIS MGM"
(Imported from text file) |
(Imported from text file) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
===== [[Summary Article|'''SUMMARY''']] ===== | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
<i>NON-PHARMACOLOGICAL </i>1. Splinting, immobilisation during acute exacerbations; slow passive ROM, heat & massage | <i>NON-PHARMACOLOGICAL </i> | ||
<br/>1. Splinting, immobilisation during acute exacerbations; slow passive ROM, heat & massage | |||
<br/> | <br/> | ||
<br/><i>ANTI-INFLAMMATORY AGENTS</i> | <br/><i>ANTI-INFLAMMATORY AGENTS</i> | ||
| Line 16: | Line 17: | ||
==Reference(s)== | ==Reference(s)== | ||
Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. | Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. [https://amzn.to/3YHrI6K Get it on Amazon.] | ||
<br/>Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. [https://amzn.to/3k7WSW0 Get it on Amazon.] | |||
<br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy. | <br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy. | ||
<br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021]. | <br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021]. | ||
Latest revision as of 02:30, 21 March 2023
SUMMARY
NON-PHARMACOLOGICAL
1. Splinting, immobilisation during acute exacerbations; slow passive ROM, heat & massage
ANTI-INFLAMMATORY AGENTS
2. Paracetamol, NSAIDs
3. Steroid injection (as only few joints involved)
NON-BIOLOGIC DMARDs
4. Sulfasalazine (well tolerated, not immunosuppressive), methotrexate, leflunomide
BIOLOGIC DMARDs
5. TNF-alpha antagonists: infliximab, adalimumab, golinumab
6. Soluble TNF receptor: etanercept
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
